SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Results of Phase I/II Clinical Trial of Diffusion Pharmaceuticals' Trans Sodium Crocetinate in Patients with Peripheral Artery Disease (PAD) to be Presented at American Heart Association Scientific Sessions